One baby dead and 14 critically ill after drip contamination
Newborn babies poisoned by contaminated batch of nutrition drips in six different NHS hospitals

A newborn baby has died and 14 others are battling septicaemia after being poisoned by a contaminated batch of nutrition drips in six different NHS hospitals.
Health chiefs last night issued a public health alert, warning that the infected product may have been used in 22 hospitals across the country.
The newborn died of blood poisoning, caused by a common bacterium known as Bacillus cereus, on Sunday at Guy's and St Thomas' Hospital in London. The other 14 babies affected are said to be responding to antibiotics in hospitals in London, Brighton, Cambridge and Luton. All of the newborns, most of whom were premature, were being fed through a tube into their bloodstream.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The contamination is believed to have been accidental, with medical regulators investigating an incident last Thursday at a London manufacturing plant owned by ITH Pharma Ltd.
Public Health England (PHE) and the Medicines and Healthcare Products Regulatory Agency (MHRA) have launched an investigation.
All of the feeds in danger of contamination have been recalled and regulators emphasised that it was unlikely that any were still in use as the batch has passed its use-by date.
Adam Finn, professor of paediatrics at University of Bristol, told the Daily Telegraph the scenario was "everyone's worst nightmare".
ITH Pharma said it was "very saddened" to hear the news. "We are co-operating fully with the MHRA in the investigation, and are doing everything we can to help them establish the facts in this case as quickly as possible," it said.
A spokesman for Guy's and St Thomas's Trust said that all babies on the unit are being screened for the bacterium as a precaution and that enhanced infection control measures had been put in place. "These enhanced measures will remain in place until the trust is satisfied that no other babies are at risk," he said.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Sail in style onboard the brand-new Explora II
The Week Recommends Hit the high seas on a luxury cruise from Barcelona to Rome
-
Is the EU funding Russia more than Ukraine?
The Explainer EU remains largest importer of Russian fossil fuels despite sanctions aimed at crippling Kremlin's war effort
-
Posh crisps: an 'elite' tier of snacking
The Week Recommends Hand-cooked and dusted in 'decadent' flavours, the humble potato chip is being elevated to new levels
-
How the care industry came to rely on migrant workers
The Explainer Government crackdown on recruiting workers abroad risks deepening care sector crisis, industry leaders warn
-
Could medics' misgivings spell the end of the assisted dying bill?
Today's Big Question The Royal College of Psychiatrists has identified 'serious concerns' with the landmark bill – and MPs are taking notice
-
Washwood Heath: Birmingham's pioneering neighbourhood health service
In the Spotlight NHS England chair says there is a 'really good argument this is the model for the future'
-
The UK's first legal drug consumption room
The Explainer 'Potentially transformative moment in UK drugs policy' as The Thistle opens in Glasgow
-
How can the UK solve the adult social care crisis?
Today's Big Question New commission announced to turn our buckling care sector around: yet more delay or finally a way forward?
-
Should blood donors be paid?
The Explainer Financial rewards would help fill NHS shortfall but bring risk of contamination and exploitation, WHO warns
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
-
A 'transformative' gene therapy for haemophilia B
The Explainer Costly treatment that could be 'truly life-changing' for patients with rare blood disorder gets funding boost